Tardy Katherine J, Kwak Hyunjee V, Tieniber Andrew D, Mangold Alina K, Perez Juan E, Do Kevin, Zeng Shan, Rossi Ferdinando, DeMatteo Ronald P
Department of Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Ann Surg Oncol. 2025 Mar;32(3):1504-1510. doi: 10.1245/s10434-024-16526-9. Epub 2024 Nov 22.
Gastrointestinal stromal tumor (GIST) is the most common human sarcoma with over 5000 new patients diagnosed in the USA each year. The tumor originates from the interstitial cells of Cajal and forms an intramural lesion most commonly in the stomach or small intestine. The gut microbiome has been linked to other gastrointestinal cancers and a recent paper purported that GISTs contain substantial intratumoral bacteria. The purpose of this study is to further evaluate the presence of bacteria in GISTs.
We collected 25 tumor samples of varying size and location from 24 patients under sterile conditions in the operating room immediately following surgical resection. 16S quantitative polymerase chain reaction (qPCR) and 16S ribosomal RNA (rRNA) gene amplicon sequencing were performed to evaluate the bacterial species present in each tumor. Retrospective chart review was performed to determine tumor characteristics, including tumor size, location, imatinib exposure, and mucosal involvement.
In 23 of the 25 tumor samples, there were fewer than 100 copy numbers of 16S rRNA per uL, indicating an absence of a significant bacterial load. 16S rRNA gene amplicon sequencing of the remaining two samples, one gastric tumor and one duodenal tumor, revealed the presence of normal intestinal bacteria. These two tumors, along with three others, had disruption of the mucosal lining.
GISTs generally lack substantial bacteria, except in some cases when the tumor disrupts the mucosa.
胃肠道间质瘤(GIST)是最常见的人类肉瘤,在美国每年有超过5000名新患者被诊断出来。该肿瘤起源于 Cajal 间质细胞,最常形成壁内病变于胃或小肠。肠道微生物群已与其他胃肠道癌症相关联,最近一篇论文声称GISTs含有大量肿瘤内细菌。本研究的目的是进一步评估GISTs中细菌的存在情况。
我们在手术室无菌条件下,于手术切除后立即从24名患者中收集了25个不同大小和位置的肿瘤样本。进行16S定量聚合酶链反应(qPCR)和16S核糖体RNA(rRNA)基因扩增子测序,以评估每个肿瘤中存在的细菌种类。进行回顾性病历审查以确定肿瘤特征,包括肿瘤大小、位置、伊马替尼暴露情况和黏膜受累情况。
在25个肿瘤样本中的23个中,每微升16S rRNA的拷贝数少于100,表明不存在显著的细菌负荷。对其余两个样本(一个胃肿瘤和一个十二指肠肿瘤)进行的16S rRNA基因扩增子测序显示存在正常肠道细菌。这两个肿瘤以及其他三个肿瘤存在黏膜内衬破坏。
GISTs通常缺乏大量细菌,除了在某些肿瘤破坏黏膜的情况下。